{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T19:16:18Z","timestamp":1774293378157,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidad de las Am\u00e9ricas","award":["4811"],"award-info":[{"award-number":["4811"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The purpose of this protocol is to provide a new systematic review with meta-analysis using the current methodology to compare the effectiveness of multicomponent treatment versus other interventions for patients with fibromyalgia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This protocol conforms to the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) and the recommendations of the Cochrane Collaboration Handbook. An electronic search will be conducted in MEDLINE, EMBASE, Web of Science, Cochrane CENTRAL, LILACS, CINAHL, and PEDro, from inception until April 2022. There will be no language restrictions. The Cochrane Collaboration tool for assessing the risk of bias (RoB2) will be used. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) scale will be used to evaluate the strength of the evidence. The Hartung-Knapp-Sidik-Jonkman random effects or Mantel-Haenszel fixed effects methods will be used, depending on the heterogeneity, to compute a pooled estimate of the mean difference (MD) or standardized mean difference (SMD) and respective 95% confidence intervals for clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This systematic review will synthesize evidence on the effectiveness of multicomponent treatment in patients with fibromyalgia and could add important evidence in the treatment of FM to improve clinical practice and decision-making\/actions in this field. This new systematic review will try to show the effects of multicomponent treatment by type (endurance, resistance, stretching, or mind-body exercises [pilates or taichi]) and intensity (light, moderate, moderate-to-vigorous, vigorous) of exercise in patients with FM. The results will be disseminated by publication in a peer-reviewed journal. Ethics approval will not be needed because the data used for this systematic review will be obtained from individual trials and there will be no concerns about privacy. However, if we identify ethical issues during the development of the systematic review, these findings will be reported in the discussion of the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>PROSPERO CRD42020142082.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13643-022-01944-1","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T22:02:50Z","timestamp":1649973770000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effectiveness of multicomponent treatment in patients with fibromyalgia: protocol for a systematic review and meta-analysis"],"prefix":"10.1186","volume":"11","author":[{"given":"Felipe","family":"Araya-Quintanilla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor","family":"Guti\u00e9rrez-Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Prieto-Lafrentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Pavez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Cristi-Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iv\u00e1n","family":"Cavero-Redondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia","family":"\u00c1lvarez-Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"issue":"6","key":"1944_CR1","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","volume":"38","author":"F Wolfe","year":"2011","unstructured":"Wolfe F, Clauw DJ, Fitzcharles M, Goldenberg DL, H\u00e4user W, Katz RS, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol. 2011;38(6):1113\u201322.","journal-title":"J Rheumatol"},{"issue":"2","key":"1944_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s12016-015-8509-4","volume":"49","author":"AT Borchers","year":"2015","unstructured":"Borchers AT, Gershwin ME. Fibromyalgia: a critical and comprehensive review. Clin Rev Allergy Immunol. 2015;49(2):100\u201351.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1944_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","volume":"17","author":"LP Queiroz","year":"2013","unstructured":"Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17:356.","journal-title":"Curr Pain Headache Rep"},{"issue":"4","key":"1944_CR4","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.rbr.2016.10.004","volume":"57","author":"AP Marques","year":"2017","unstructured":"Marques AP, Santo ASDE, Berssaneti AA, Matsutani LA, Yuan SLK. Prevalence of fibromyalgia: literature review update. Rev Bras Reumatol Engl Ed. 2017;57(4):356\u201363.","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"1944_CR5","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1080\/09638280400009089","volume":"27","author":"CM Henriksson","year":"2005","unstructured":"Henriksson CM, Liedberg GM, Gerdle B. Women with fibromyalgia: work and rehabilitation. Disabil Rehabil. 2005;27:685\u201394.","journal-title":"Disabil Rehabil"},{"key":"1944_CR6","first-page":"1391","volume":"31","author":"JR Penrod","year":"2004","unstructured":"Penrod JR, Bernatsky S, Adam V, Baron M, Dayan N, Dobkin PL. Health services costs and their determinants in women with fibromyalgia. J Rheumatol. 2004;31:1391\u20138.","journal-title":"J Rheumatol"},{"key":"1944_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1517\/14656566.7.8.1027","volume":"7","author":"RL Robinson","year":"2006","unstructured":"Robinson RL, Jones ML. In search of pharmacoeconomic evaluations for fibromyalgia treatments: a review. Expert Opin Pharmacother. 2006;7:1027\u201339.","journal-title":"Expert Opin Pharmacother"},{"key":"1944_CR8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1136\/ard.2007.071522","volume":"67","author":"SF Carville","year":"2008","unstructured":"Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, et al. EULAR evidence based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67:536\u201341.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1944_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejpain.2009.01.006","volume":"14","author":"W H\u00e4user","year":"2010","unstructured":"H\u00e4user W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome - a systematic review. Eur J Pain. 2010;14(1):5\u201310.","journal-title":"Eur J Pain"},{"key":"1944_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/annrheumdis-2011-201249","volume":"72","author":"E N\u00fcesch","year":"2013","unstructured":"N\u00fcesch E, H\u00e4user W, Bernardy K, et al. Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis. Ann Rheum Dis. 2013;72:955\u201362.","journal-title":"Ann Rheum Dis"},{"key":"1944_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1358\/dot.2011.47.7.1603503","volume":"47","author":"C Han","year":"2011","unstructured":"Han C, Lee SJ, Lee SY, Seo HJ, Wang SM, Park MH, et al. Available therapies and current management of fibromyalgia: focusing on pharmacological agents. Drugs Today (Barc). 2011;47:539\u201357.","journal-title":"Drugs Today (Barc)"},{"issue":"7","key":"1944_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1080\/00325481.2017.1336417","volume":"129","author":"LM Arnold","year":"2017","unstructured":"Arnold LM, Clauw DJ. Challenges of implementing fibromyalgia treatment guidelines in current clinical practice. Postgrad Med. 2017;129(7):709\u201314.","journal-title":"Postgrad Med"},{"issue":"4","key":"1944_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/14728214.2017.1418323","volume":"22","author":"F Atzeni","year":"2017","unstructured":"Atzeni F, Gerardi MC, Masala IF, Alciati A, Batticciotto A, Sarzi-Puttini P. An update on emerging drugs for fibromyalgia treatment. Expert Opin Emerg Drugs. 2017;22(4):357\u201367.","journal-title":"Expert Opin Emerg Drugs"},{"issue":"2","key":"1944_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/art.24276","volume":"61","author":"W H\u00e4user","year":"2009","unstructured":"H\u00e4user W, Bernardy K, Arnold B, Offenb\u00e4cher M, Schiltenwolf M. Efficacy of multicomponent treatment in fibromyalgia syndrome: a meta-analysis of randomized controlled clinical trials. Arthritis Care Res. 2009;61(2):216\u201324.","journal-title":"Arthritis Care Res"},{"issue":"10","key":"1944_CR15","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00296-016-3473-8","volume":"36","author":"I Saral","year":"2016","unstructured":"Saral I, Sindel D, Esmaeilzadeh S, Sertel-Berk HO, Oral A. The effects of long- and short-term interdisciplinary treatment approaches in women with fibromyalgia: a randomized controlled trial. Rheumatol Int. 2016;36(10):1379\u201389.","journal-title":"Rheumatol Int"},{"key":"1944_CR16","volume":"2013","author":"J Ablin","year":"2013","unstructured":"Ablin J, Fitzcharles MA, Buskila D, et al. Treatment of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines with special emphasis on complementary and alternative therapies. Evid Based Complement Alternat Med. 2013;2013:485272.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1944_CR17","first-page":"CD010884","volume":"12","author":"AJ Busch","year":"2013","unstructured":"Busch AJ, Webber SC, Richards RS, Bidonde J, Schachter CL, Schafer LA, et al. Resistance exercise training for fibromyalgia. Cochrane Database Syst Rev. 2013;12:CD010884.","journal-title":"Cochrane Database Syst Rev"},{"key":"1944_CR18","first-page":"CD009796","volume":"9","author":"K Bernardy","year":"2013","unstructured":"Bernardy K, Klose P, Busch AJ, et al. Cognitive behavioural therapies for fibromyalgia. Cochrane Database Syst Rev. 2013;9:CD009796.","journal-title":"Cochrane Database Syst Rev"},{"key":"1944_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jpsychores.2017.05.004","volume":"98","author":"M Van Den Houte","year":"2017","unstructured":"Van Den Houte M, Luyckx K, Van Oudenhove L, Bogaerts K, Van Diest I, De Bie J, et al. Differentiating progress in a clinical group of fibromyalgia patients during and following a multicomponent treatment program. J Psychosom Res. 2017;98:47\u201354.","journal-title":"J Psychosom Res"},{"key":"1944_CR20","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00482-012-1173-1","volume":"26","author":"B Arnold","year":"2012","unstructured":"Arnold B, H\u00e4user W, Arnold M, et al. Multicomponent therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline. Schmerz. 2012;26:287\u201390.","journal-title":"Schmerz"},{"issue":"7","key":"1944_CR21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jpain.2016.12.006","volume":"18","author":"K Thieme","year":"2017","unstructured":"Thieme K, Mathys M, Turk DC. Evidenced-based guidelines on the treatment of fibromyalgia patients: are they consistent and if not, why not? Have effective psychological treatments been overlooked? J Pain. 2017;18(7):747\u201356.","journal-title":"J Pain"},{"issue":"2","key":"1944_CR22","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","volume":"76","author":"GJ Macfarlane","year":"2017","unstructured":"Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, H\u00e4user W, Flu\u00df E, et al. EULAR revised recommendations for the management of fibromialgia. Ann Rheum Dis. 2017;76(2):318\u201328.","journal-title":"Ann Rheum Dis"},{"key":"1944_CR23","unstructured":"Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. London: National Institute for Health and Care Excellence (NICE); 2021. (NICE Guideline, No. 193.) Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK569960\/."},{"issue":"3","key":"1944_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00482-017-0205-2","volume":"31","author":"M Schiltenwolf","year":"2017","unstructured":"Schiltenwolf M, Eidmann U, K\u00f6llner V, K\u00fchn T, Offenb\u00e4cher M, Petzke F, et al. Multimodal therapy of fibromyalgia syndrome: updated guidelines 2017 and overview of systematic review articles. Schmerz. 2017;31(3):285\u20138.","journal-title":"Schmerz."},{"issue":"3","key":"1944_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s00482-008-0678-0","volume":"22","author":"B Arnold","year":"2008","unstructured":"Arnold B, H\u00e4user W, Bernardy K, Br\u00fcckle W, Friedel E, K\u00f6llner V, et al. Multicomponent therapy for treatment of fibromyalgia syndrome. Schmerz. 2008;22(3):334\u20138.","journal-title":"Schmerz."},{"key":"1944_CR26","volume-title":"Noninvasive nonpharmacological treatment for chronic pain: a systematic review","author":"AC Skelly","year":"2018","unstructured":"Skelly AC, Chou R, Dettori JR, Turner JA, Friedly JL, Rundell SD, et al. Noninvasive nonpharmacological treatment for chronic pain: a systematic review. Rockville: Agency for Healthcare Research and Quality (US); 2018. Report No.: 18-EHC013-EF"},{"key":"1944_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"key":"1944_CR28","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane. 2021. Available from www.training.cochrane.org\/handbook."},{"key":"1944_CR29","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010;62:600\u201310.","journal-title":"Arthritis Care Res"},{"issue":"366","key":"1944_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;28(366):l4898.","journal-title":"BMJ."},{"issue":"4","key":"1944_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","volume":"64","author":"H Balshem","year":"2011","unstructured":"Balshem H, Helfand M, Sch\u00fcnemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401\u20136.","journal-title":"J Clin Epidemiol"},{"key":"1944_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","volume":"119","author":"N Santesso","year":"2020","unstructured":"Santesso N, Glenton C, Dahm P, Garner P, Akl EA, Alper B, et al. GRADE Working Group. GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol. 2020;119:126\u201335.","journal-title":"J Clin Epidemiol"},{"issue":"14","key":"1944_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-2288-14-25","volume":"18","author":"J IntHout","year":"2014","unstructured":"IntHout J, Ioannidis JP, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014;18(14):25.","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"1944_CR34","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta\u2013analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"7304","key":"1944_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/bmj.323.7304.101","volume":"323","author":"JA Sterne","year":"2001","unstructured":"Sterne JA, Egger M, Smith GD. Systematic reviews in healthcare: investigating and dealing with publication and other biases in meta-analysis. BMJ. 2001;323(7304):101\u20135.","journal-title":"BMJ."},{"issue":"9","key":"1944_CR36","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00296-017-3725-2","volume":"37","author":"F Heidari","year":"2017","unstructured":"Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int. 2017;37(9):1527\u201339.","journal-title":"Rheumatol Int"},{"issue":"2","key":"1944_CR37","first-page":"CD010585","volume":"2","author":"J Thorpe","year":"2018","unstructured":"Thorpe J, Shum B, Moore RA, Wiffen PJ, Gilron I. Combination pharmacotherapy for the treatment of fibromyalgia in adults. Cochrane Database Syst Rev. 2018;2(2):CD010585.","journal-title":"Cochrane Database Syst Rev"},{"key":"1944_CR38","doi-asserted-by":"crossref","unstructured":"Serrat M, Sanabria-Mazo JP, Almirall M, Must\u00e9 M, Feliu-Soler A, M\u00e9ndez-Ulrich JL, Sanz A, Luciano JV. Effectiveness of a Multicomponent Treatment Based on Pain Neuroscience Education, Therapeutic Exercise, Cognitive Behavioral Therapy, and Mindfulness in Patients With Fibromyalgia (FIBROWALK Study): A Randomized Controlled Trial. Phys Ther. 2021;101(12):pzab200.","DOI":"10.1093\/ptj\/pzab200"},{"issue":"11","key":"1944_CR39","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1097\/j.pain.0000000000001655","volume":"160","author":"A P\u00e9rez-Aranda","year":"2019","unstructured":"P\u00e9rez-Aranda A, Feliu-Soler A, Montero-Mar\u00edn J, Garc\u00eda-Campayo J, Andr\u00e9s-Rodr\u00edguez L, Borr\u00e0s X, et al. A randomized controlled efficacy trial of mindfulness-based stress reduction compared with an active control group and usual care for fibromyalgia: the EUDAIMON study. Pain. 2019;160(11):2508\u201323.","journal-title":"Pain."},{"issue":"1 Suppl 88","key":"1944_CR40","first-page":"S93","volume":"33","author":"F Salaffi","year":"2015","unstructured":"Salaffi F, Ciapetti A, Gasparini S, Atzeni F, Sarzi-Puttini P, Baroni M. Web\/Internet-based telemonitoring of a randomized controlled trial evaluating the time-integrated effects of a 24-week multicomponent intervention on key health outcomes in patients with fibromyalgia. Clin Exp Rheumatol. 2015;33(1 Suppl 88):S93\u2013101.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"1944_CR41","doi-asserted-by":"publisher","first-page":"e0126324","DOI":"10.1371\/journal.pone.0126324","volume":"10","author":"P Bourgault","year":"2015","unstructured":"Bourgault P, Lacasse A, Marchand S, Courtemanche-Harel R, Charest J, Gaumond I, et al. Multicomponent interdisciplinary group intervention for self-management of fibromyalgia: a mixed-methods randomized controlled trial. PLoS One. 2015;10(5):e0126324.","journal-title":"PLoS One"},{"issue":"5","key":"1944_CR42","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/ijcp.12365","volume":"68","author":"J Mart\u00edn","year":"2014","unstructured":"Mart\u00edn J, Torre F, Padierna A, Aguirre U, Gonz\u00e1lez N, Matellanes B, et al. Impact of interdisciplinary treatment on physical and psychosocial parameters in patients with fibromyalgia: results of a randomised trial. Int J Clin Pract. 2014;68(5):618\u201327.","journal-title":"Int J Clin Pract"},{"issue":"10","key":"1944_CR43","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.3390\/jcm9103348","volume":"9","author":"M Serrat","year":"2020","unstructured":"Serrat M, Almirall M, Must\u00e9 M, Sanabria-Mazo JP, Feliu-Soler A, M\u00e9ndez-Ulrich JL, et al. Effectiveness of a multicomponent treatment for fibromyalgia based on pain neuroscience education, exercise therapy, psychological support, and nature exposure (NAT-FM): a pragmatic randomized controlled trial. J Clin Med. 2020;9(10):3348.","journal-title":"J Clin Med"},{"issue":"9","key":"1944_CR44","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1517\/14656566.2015.1047343","volume":"16","author":"EP Calandre","year":"2015","unstructured":"Calandre EP, Rico-Villademoros F, Slim M. An update on pharmacotherapy for the treatment of fibromyalgia. Expert Opin Pharmacother. 2015;16(9):1347\u201368.","journal-title":"Expert Opin Pharmacother"},{"key":"1944_CR45","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S0025-6196(11)62386-0","volume":"76","author":"L Worrel","year":"2001","unstructured":"Worrel L, Krahn L, Sletten C, Pond G. Treating fibromyalgia with a brief interdisciplinary program: initial outcomes and predictors of response. Mayo Clin Proc. 2001;76:384\u201390.","journal-title":"Mayo Clin Proc"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-022-01944-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-022-01944-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-022-01944-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T23:34:06Z","timestamp":1650065646000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-022-01944-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1944"],"URL":"https:\/\/doi.org\/10.1186\/s13643-022-01944-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-127742\/v1","asserted-by":"object"}]},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"assertion":[{"value":"10 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}